Lipocine Inc.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $3.2M $5.6M $20.0M $27.7M $45.3M $5.4M $8.6M
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $25.2M $27.2M $44.9M $27.9M $46.0M $5.5M $32.4K
Property, Plant & Equipment $75.1K $103.4K $75.8K $73.8K $28.8K $49.4K —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $25.3M $27.3M $45.4M $28.0M $46.1M $5.6M $32.4K
Liabilities
Accounts Payable $598.1K $245.9K $507.1K $306.3K $1.0M $87.0K $7.4K
Total Current Liabilities $6.3M $1.3M $3.4M $1.6M $1.3M $212.8K $7.6K
Long-Term Debt $0 — — — — — —
Total Liabilities $6.3M $1.3M $3.4M $1.6M $1.3M $250.0K $-1.3M
Stockholders' Equity
Retained Earnings $-126.4M $-105.4M $-86.4M $-68.2M $-47.9M $-37.3M —
Total Stockholders' Equity $19.0M $26.0M $42.0M $26.4M $44.8M $5.3M $1.3M
← Newer Page 2 of 2 Older →